Innovatively, our study employed bivariate combined indices to predict treatment responses in SLE-ITP patients and constructed the first combined predictive model integrating complement C3, NLR, and SII, significantly enhancing the predictive capability of individual indices. The gene discussed is C3; the disease is systemic lupus erythematosus.